Enable Injections Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Enable Injections and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 200 Enable Injections employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Enable Injections has purchased the following applications: Rackspace Cloud for Application Hosting and Computing Services in 2016, New Relic APM for Application Performance Management in 2023, Python for Apps Development in 2016 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Enable Injections is running and its propensity to invest more and deepen its relationship with Rackspace Technology , Liquid Web , Google or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Enable Injections revenues, which have grown to $30.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Enable Injections intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.